-
Enjoying the moment: Alcaraz steps it up to reach US Open quarter-finals
-
Tiafoe tops Medvedev in straight sets at US Open
-
Five dead, five injured after Amazon cargo plane overshoots Miami runway
-
Zverev seeks US Open last eight as Osaka faces Rybakina
-
La Rochelle half-backs lead fightback against Toulouse
-
Alcaraz turns up heat to reach US Open quarters
-
US envoys have 'more effective proposals': Ukraine official
-
Gatti salvages Juve draw with AC Milan in Serie A
-
Defending champion Alcaraz powers into US Open quarter-finals
-
Sinayoko stars as unbeaten Paris FC down Marseille
-
Amazon cargo plane overshoots Miami runway, hits vehicles, catches fire
-
Still on top: 'Spider-Man' dominates North American box office
-
Toll from Yemen clashes passes 300 as civilians flee homes
-
Zelensky in fresh talks with US envoys: Ukraine official
-
Sabalenka books US Open quarter-final clash with Noskova
-
Noskova edges Kostyuk to reach US Open quarter-finals
-
German AfD supporters jubilant at far right's thumping win
-
Alonso urges Chelsea to learn from painful defeat at Arsenal
-
Zelensky warns war likely to continue into winter after US talks
-
Defending champion Sabalenka reaches US Open quarter-finals
-
Arsenal deliver statement fightback to end Chelsea's flying start
-
Minnows Augsburg sink Frankfurt to top Bundesliga table
-
Leclerc accepts blame as Hamilton laments Ferrari approach
-
Yamal hits double as 'nearly perfect' Barca thrash Valencia
-
Sabalenka surges past Townsend to reach US Open quarter-finals
-
Antonelli living 'a dream' after astonishing home win
-
Smiling face of Germany's far-right AfD: Ulrich Siegmund
-
Impressive Daryz keeps Arc double dream alive
-
Lebanon president calls for US help as Israeli strikes kill 7
-
Strasbourg hit Troyes for six as Amo-Ameyaw sparkles
-
Yamal hits double as perfect Barca thrash Valencia
-
German far-right AfD landslide winner in eastern state vote
-
Venice festival turns gaze on war reporters, media industry
-
Carrick defends Man Utd start despite defensive concerns
-
Sensational Antonelli wins Italian GP from back of grid
-
More than 140 killed in latest Yemen clashes: military sources
-
Susan Sarandon says still losing roles over Gaza stance
-
Van Aert claims shortened Vuelta stage 15 win in high heat
-
US envoys hold 'important' talks in first trip to Kyiv
-
Everton shrug off transfer window woes to hold Man Utd
-
Championship leader Antonelli wins Italian Grand Prix
-
'Nothing has changed': FIFA confirms Infantino to run for re-election
-
Vardy signs for Championship strugglers Burnley
-
UN's Nepal chief makes emotional plea for flood-ravaged country
-
FIFA confirms Infantino will run in presidential election
-
Italian GP red-flagged after massive Leclerc crash
-
With joy and grief, Palestinian football marks return
-
US envoys hold talks with Zelensky on first Kyiv visit
-
Iran threatens greater force if US launches more attacks
-
'Truly scared': Blazes outpace firefighters in Indonesian Borneo
Appetite-regulating hormones in focus as first Nobel Prizes fall
Research into hormones that regulate appetite is seen leading the race for the Nobel Prize in Medicine, to be awarded Monday -- the first in this year's Nobel season.
At a time when more than one billion people suffer from obesity, research into the hormone called "glucagon-like peptide 1" (GLP-1) could be given the nod for the Nobel Prize in Physiology or Medicine this year, experts said.
A new generation of drugs using GLP-1 agonists -- including blockbuster brands Ozempic, Wegovy and Mounjaro -- has provided a valuable tool to fight obesity and diabetes globally.
"Many are guessing that it (the Nobel Prize in Medicine) will go to the people behind GLP-1," Lars Brostrom, science editor at public broadcaster Sveriges Radio, told AFP.
That could help researchers from major US institutions once again dominate the Nobel Prizes in sciences, which are to be announced this week in Stockholm.
But, even if that happens, US politics is to cast a shadow over them, given budget cuts to science programmes ordered by President Donald Trump's government.
Since January, the US National Institutes of Health (NIH) has terminated 2,100 research grants totalling around $9.5 billion and $2.6 billion in contracts, according to an independent database called Grant Watch.
Such cuts could fuel debate over the growing risk that the United States could lose its edge in scientific research.
"In the post-war period, the US has taken over Germany's role as the world's leading scientific nation," Hans Ellegren, secretary general of the Royal Swedish Academy of Sciences, which awards Nobel Prizes in physics, chemistry, and economics, told AFP.
"When they now start cutting research funding, it threatens the country's position."
- Many contenders -
When it comes to GLP-1, as with many other discoveries, it can be hard to narrow down who exactly deserves to be honoured when many scientists around the world have made significant contributions.
Brostrom said some names often speculated upon are Danish physician Jens Juul Holst, and Joel Habener, a professor of medicine at Harvard, as well as Canadian endocrinologist Daniel Drucker and Yugoslav-born American chemist Svetlana Mojsov.
Despite treatments such as Ozempic being recently introduced, and the Nobel Assembly at the Karolinska Institute more often honouring discoveries that are decades old, "it could also be perfect timing" for GLP-1 recognition "because the discovery itself was made back in the 80s", Brostrom said.
In the same field, research on ghrelin, a hormone that stimulates appetite, could earn a Nobel Prize for two Japanese researchers, Kenji Kangawa and Masayasu Kojima, according to David Pendlebury, who heads research analysis at the firm Clarivate -- which predicts potential Nobel winners based on the number of citations of their work.
Pendlebury said that would also form "a nice bookend to a 1994 discovery" by geneticist Jeffrey Friedman, who discovered another appetite-regulating hormone, leptin, and who has previously been spotlighted by Clarivate.
"We have a combination of very nice discoveries, a hormone for appetite, a hormone that suppresses appetite, and this may also play into a lot of speculation of a prize for the GLP-1," he told AFP.
Clarivate also said the work of German medical professor Andrea Ablasser, American virologist Glen N. Barber, and Chinese-American biochemist Zhijian "James" Chen could be honoured "for elucidating the cGAS-STING pathway, a fundamental mechanism of innate immunity".
It noted that Canadian biologist John E. Dick could also be a contender "for identifying leukaemia stem cells and establishing their relevance in therapy failure".
- 'Invisibility cloak' -
For the Nobel Prize in Physics on Tuesday, experts at Sweden's public radio cited research into metamaterials, which has been buzzed about for several years.
British physicist John B. Pendry has in particular been frequently mentioned for his "invisibility cloak" -- a theoretical method to redirect electromagnetic fields around an object.
The Nobel season continues Wednesday with the prize for chemistry, followed on Thursday by the closely watched literature prize and on Friday the peace prize, which Donald Trump has argued should go to him.
The economics prize wraps up the Nobel season on October 13.
In addition to each honour, the prize includes a diploma, a gold medal, and a check for 11 million Swedish kronor ($1.2 million).
J.Williams--AMWN